annual CAPEX:
N/ASummary
- KALV annual capital expenditures is not available.
Performance
KALV CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
quarterly CAPEX:
N/ASummary
- KALV quarterly capital expenditures is not available.
Performance
KALV quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM CAPEX:
N/ASummary
- KALV TTM capital expenditures is not available.
Performance
KALV TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
KALV CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
KALV CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time |
KALV CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Apr 2020 | $220.00K(-79.6%) | $8000.00(>+9900.0%) | $220.00K(-54.8%) |
Jan 2020 | - | $0.00(-100.0%) | $487.00K(-3.9%) |
Oct 2019 | - | $114.00K(+16.3%) | $507.00K(-17.4%) |
Jul 2019 | - | $98.00K(-64.4%) | $614.00K(-43.2%) |
Apr 2019 | $1.08M(-24.2%) | $275.00K(+1275.0%) | $1.08M(-42.8%) |
Jan 2019 | - | $20.00K(-91.0%) | $1.89M(-7.9%) |
Oct 2018 | - | $221.00K(-60.9%) | $2.05M(+9.0%) |
Jul 2018 | - | $565.00K(-47.9%) | $1.88M(+31.9%) |
Apr 2018 | $1.43M(+1828.4%) | $1.08M(+495.6%) | $1.43M(+316.0%) |
Jan 2018 | - | $182.00K(+256.9%) | $343.00K(+113.0%) |
Oct 2017 | - | $51.00K(-53.6%) | $161.00K(+46.4%) |
Jul 2017 | - | $110.00K(>+9900.0%) | $110.00K(-91.8%) |
Apr 2017 | $74.00K | - | - |
Sep 2016 | - | $0.00(-100.0%) | $1.34M(-1.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2016 | - | $61.00K(-66.8%) | $1.36M(-1.3%) |
Apr 2016 | $11.00K(-99.2%) | - | - |
Mar 2016 | - | $184.00K(-83.2%) | $1.38M(+0.3%) |
Dec 2015 | $1.37M(+999.2%) | $1.09M(+5109.5%) | $1.37M(+286.0%) |
Sep 2015 | - | $21.00K(-73.4%) | $356.00K(+4.1%) |
Jun 2015 | - | $79.00K(-56.1%) | $342.00K(+1.2%) |
Apr 2015 | $125.00K(-21.4%) | - | - |
Mar 2015 | - | $180.00K(+136.8%) | $338.00K(+112.6%) |
Dec 2014 | $159.00K(+783.3%) | $76.00K(+985.7%) | $159.00K(+91.6%) |
Sep 2014 | - | $7000.00(-90.7%) | $83.00K(+9.2%) |
Jun 2014 | - | $75.00K(+7400.0%) | $76.00K(+7500.0%) |
Mar 2014 | - | $1000.00 | $1000.00 |
Dec 2013 | $18.00K(-80.2%) | - | - |
Dec 2012 | $91.00K | - | - |
FAQ
- What is the all time high annual CAPEX for KalVista Pharmaceuticals?
- What is the all time high quarterly CAPEX for KalVista Pharmaceuticals?
- What is the all time high TTM CAPEX for KalVista Pharmaceuticals?
What is the all time high annual CAPEX for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual capital expenditures is $1.43M
What is the all time high quarterly CAPEX for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly capital expenditures is $1.09M
What is the all time high TTM CAPEX for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high TTM capital expenditures is $2.05M